ENTITY
CanSino Biologics

CanSino Biologics (688185 CH)

112
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
SparkleRequest Primer
Publication Icon
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.
Back to "All"
x